Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Affect Disord ; 235: 142-149, 2018 08 01.
Article in English | MEDLINE | ID: mdl-29656258

ABSTRACT

BACKGROUND: For treating affective disorders like SAD, light therapy is used although the underlying mechanism explaining this success remains unclear. To accelerate the research on defining the light characteristics responsible for inducing a specific effect a uniform manner for specifying the irradiance at the eye should be defined. This allows a genuine comparison between light-affect studies. An important factor impacting the irradiance at the eye are the radiant characteristics of the used light therapy device. METHOD: In this study the radiant fluxes of five different light therapy devices were measured. The values were weighted against the spectral sensitivity of the five photopigments present in the human eye. A measurement was taken every five minutes to control for a potential stabilizing effect. RESULTS: The results show that all five devices show large differences in radiant flux. The devices equipped with blue LED lights have a much lower spectral radiant flux than the devices equipped with a fluorescent light source or a white LED. The devices with fluorescent lamps needed 30 min to stabilize to a constant radiant flux. LIMITATIONS: In this study only five devices were measured. Radiant flux is just the first step to identify uniform specifications for light therapy devices. CONCLUSIONS: It is recommended to provide all five α-opic radiant fluxes. Preferably, the devices should come with a spectral power distribution of the radiant flux. For the devices equipped with a fluorescent lamp it is recommended to provide information on the stabilization time.


Subject(s)
Mood Disorders/therapy , Photometry/standards , Phototherapy/instrumentation , Humans , Reference Standards
2.
Technol Health Care ; 25(2): 171-186, 2017.
Article in English | MEDLINE | ID: mdl-27689558

ABSTRACT

BACKGROUND: The non-image-forming effects of luminous radiation on people with intellectual disabilities or dementia received attention from researchers. Such studies, however, have generally been conducted using disparate methodologies which precludes generalization and reproducibility. OBJECTIVE: The aim of this study was to determine the practical applicability of measurement devices for studies investigating non-image-forming effects of luminous radiation, specifically for people with intellectual disabilities or dementia. METHODS: In three experiments, ten cognitive impaired people and thirty-nine unaffected subjects participated by wearing one or more portable devices. Six devices were assessed in total. Measurement data was accompanied with user experiences obtained from questionnaires, interviews and observations in order to assess the devices on practical and comfort issues. RESULTS: On average, the devices worn by the cognitive impaired subjects were not experienced as annoying or irritating. No significant differences are found between genders and for one of the portable devices significantly less annoyance was reported by the cognitive impaired participants compared to the unaffected group of participants. INNOVATIVE SOLUTION: The three phases of the research process in towards measuring personal luminous exposures are: selection of the most suitable portable device, application of the assessment method, and the application of the device in the (pilot) study. CONCLUSIONS: However, the findings of this study suggest that inaccuracies potentially caused by practical and comfort issues associated with the portable devices need to be considered.


Subject(s)
Cognitive Dysfunction , Light , Luminescent Measurements/instrumentation , Circadian Rhythm
3.
Praxis (Bern 1994) ; 101(20): 1297-307, 2012 Oct 03.
Article in German | MEDLINE | ID: mdl-23032495

ABSTRACT

Minimally invasive treatments of varicosis are increasingly establishing. Short and intermediate-term outcomes of endovenous treatments are satisfying: success rates are comparable with conventional surgery, whereas recovery is faster and complication rates are lower. Success rates are highest for endovenous laser ablation (EVLA). However, endovenous radiofrequency ablation (RFA) has advanced. Its short term outcomes are now comparable to EVLA, but with less side-effects. Ultrasound guided foam sclerotherapy (UGFS) replaced other forms of liquid sclerotherapy. In principle, this treatment can be combined with every other treatment for varicosis, but it loses its position as a monotherapy, due to poorer intermediate-term outcomes compared with EVLA and RFA. More prospective randomized controlled trials are needed in order to state an evidence based hierarchy of treatments for varicosis. With the minimally invasive treatments it is possible to treat patients on an outpatient basis. It will have to be assessed whether this will lead to higher cost-effectiveness.


Subject(s)
Minimally Invasive Surgical Procedures/methods , Varicose Veins/surgery , Catheter Ablation/methods , Dosage Forms , Humans , Laser Therapy/methods , Leg/blood supply , Sclerosing Solutions/administration & dosage , Sclerotherapy/methods , Secondary Prevention , Treatment Outcome , Ultrasonography, Interventional/methods , Veins/surgery
5.
Praxis (Bern 1994) ; 99(14): 833-41, 2010 Jul 07.
Article in German | MEDLINE | ID: mdl-20607666

ABSTRACT

Paracetamol is the first choice mediation for osteoarthritis. The analgetic potential of NSAIDs is slightly higher and they also have some antiphlogistic effect, but their use has to be strictly limited to a short period of time. They should mainly be used in the therapy of the acute and painful phase of osteoarthritis. Among the NSAIDs, Diclofenac is the medication of first choice. In patients with an increased risk of gastrointestinal complications, a protonpumpinhibitor should be added. Patients with cardiovascular risk factors should receive NSAIDs only in case of no appropriate alternative treatments. Opioids have their place in osteoarthritis treatment and should be part of an individualized pain regime, which should also contain a pain diary and proactive monitoring. It is important to emphasize the positive effects of physical activity on the function of the joints as well as the negative effect of overweight and immobility.


Subject(s)
Analgesics/administration & dosage , Antirheumatic Agents/administration & dosage , Evidence-Based Medicine , Osteoarthritis/drug therapy , Acetaminophen/administration & dosage , Acetaminophen/adverse effects , Analgesics/adverse effects , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/adverse effects , Anti-Ulcer Agents/administration & dosage , Antirheumatic Agents/adverse effects , Cyclooxygenase 2 Inhibitors/administration & dosage , Cyclooxygenase 2 Inhibitors/adverse effects , Diclofenac/administration & dosage , Diclofenac/adverse effects , Humans , Osteoarthritis/diagnosis
6.
Praxis (Bern 1994) ; 98(13): 717-20, 2009 Jun 24.
Article in German | MEDLINE | ID: mdl-19551657

ABSTRACT

A 35-year old man with coldness, paleness, numbness, and pain at Dig. IV of the left hand comes to the consultation. The Allen test is pathological, the angiography shows an occlusion at the length of 4 cm of the Arteria ulnaris beginning at the Hamulus ossis hamati. After therapy with prostaglandin E1, aspirin 100 mg for 10 days and a smoking stop, the symptom disappeared at the re-consultation after 10 days.


Subject(s)
Angiography , Fingers/blood supply , Hand/blood supply , Ischemia/etiology , Occupational Diseases/diagnosis , Thrombosis/diagnosis , Ulnar Artery , Ultrasonography, Doppler, Color , Adult , Collateral Circulation/physiology , Diagnosis, Differential , Humans , Ischemia/diagnosis , Male
7.
Ann Rheum Dis ; 68(2): 228-33, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18375539

ABSTRACT

BACKGROUND: Antineutrophil cytoplasmic antibodies (ANCA) with a C-ANCA or P-ANCA pattern are detected in ANCA-associated vasculitis (AAV). While in most patients with AAV a C-ANCA pattern is due to reactivity with proteinase-3 (PR3)-ANCA, some C-ANCA-positive sera do not react with PR3. OBJECTIVE: The development and evaluation of a direct enzyme-linked immunosorbent assay (ELISA) for PR3-ANCA with increased sensitivity. METHODS: A mixture of human native (hn) and human recombinant (hr) PR3 was used as antigen coating. The resulting ELISA (anti-PR3-hn-hr) was compared with ELISAs using directly coated hn-PR3 or hr-PR3, as well as with a hn-PR3 capture ELISA. Assay characteristics were determined in patients with AAV (n = 248), with special attention for those patients with C-ANCA (n = 132), as well as disease controls (n = 585) and healthy controls (n = 429). Additionally, for prediction of relapses serial samples of 46 patients with PR3-AAV were analysed. RESULTS: At a predefined specificity of 99% both ELISAs containing hr-PR3 revealed a substantial increase in sensitivity. For the prediction of relapses by rises in PR3-ANCA titres the capture ELISA was most optimal (odds ratio 12.5). With an odds ratio of 8.9 the novel anti-PR3-hn-hr ELISA was second best. CONCLUSIONS: Owing to the very high sensitivity of the novel anti-PR3-hn-hr ELISA for the detection of PR3-ANCA in C-ANCA-positive samples of patients with AAV this assay has an excellent diagnostic performance. This feature is combined with a good predictability of clinical relapses in patients with PR3-AAV. These characteristics challenge the dogma that, for detection of PR3-ANCA, capture ELISAs are superior for diagnosis and follow-up.


Subject(s)
Antibodies, Antineutrophil Cytoplasmic/blood , Autoimmune Diseases/diagnosis , Myeloblastin/immunology , Vasculitis/diagnosis , Autoimmune Diseases/immunology , Biomarkers/blood , Enzyme-Linked Immunosorbent Assay/methods , Humans , Prognosis , Recombinant Proteins/immunology , Recurrence , Sensitivity and Specificity , Vasculitis/immunology
8.
Br J Haematol ; 133(3): 337-44, 2006 May.
Article in English | MEDLINE | ID: mdl-16643437

ABSTRACT

It has increasingly been acknowledged that only a few leukaemic cells possess the capability to renew themselves and that only these self-renewing leukaemic stem cells are able to initiate relapses. Therefore, these leukaemic stem cells should be the target cells for therapy and for minimal residual disease (MRD) detection. Because of its presence on blasts of 11q23-rearranged high-risk leukaemic patients, neuron-glial antigen 2 (NG2) is thought to be a valuable marker for detecting leukaemic stem cells. Six acute myeloid leukaemia (AML)/abn(11q23) and three acute lymphoblastic leukaemia (ALL)/t(4;11) samples were analysed by four-colour flow cytometry for NG2 expression on primitive cell populations. Candidate leukaemic cell populations were defined by the antigen profiles CD34+CD38- in AML and CD34+CD19-CD117+ in ALL. Surprisingly, in all patients these candidate stem cell populations were shown to lack expression of NG2. Instead, a correlation between the expression of the myeloid differentiation marker CD33 and increasing levels of NG2 on maturing cells could be demonstrated. Similarly, in ALL patients CD34+CD19+ cells showed a higher expression of NG2 mRNA compared with CD34+CD19-. Thus, NG2 appears to be upregulated with differentiation and not to be expressed on primitive disease-maintaining cells. This hampers the clinical use of NG2 as a therapeutic target and as a sensitive marker for MRD detection.


Subject(s)
Antigens/metabolism , Biomarkers, Tumor/metabolism , Leukemia, Myeloid/metabolism , Neoplastic Stem Cells/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Proteoglycans/metabolism , Acute Disease , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Chromosomes, Human, Pair 11/genetics , Chromosomes, Human, Pair 4/genetics , Flow Cytometry/methods , Humans , Leukemia, Myeloid/genetics , Neoplasm Proteins/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Sialic Acid Binding Ig-like Lectin 3 , Translocation, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...